Synsam AB (publ) (STO:SYNSAM)
Sweden · Delayed Price · Currency is SEK 52.70
-0.80 (-1.50%)
Aug 1, 2025, 5:29 PM CET
Chimerix Revenue
In the year 2024, Synsam AB had annual revenue of 6.44B SEK with 8.98% growth. Synsam AB had revenue of 1.63B in the quarter ending December 31, 2024, with 10.35% growth.
Revenue
6.44B
Revenue Growth
+8.98%
P/S Ratio
1.18
Revenue / Employee
1.72M
Employees
3,739
Market Cap
7.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.44B | 530.00M | 8.98% |
| Dec 31, 2023 | 5.91B | 628.00M | 11.90% |
| Dec 31, 2022 | 5.28B | 608.00M | 13.02% |
| Dec 31, 2021 | 4.67B | 863.00M | 22.67% |
| Dec 31, 2020 | 3.81B | 65.40M | 1.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.50B |
| Camurus AB | 2.27B |
| Medicover AB | 25.22B |
| Asker Healthcare Group AB | 15.88B |
| Bonesupport Holding AB | 1.06B |
| AddLife AB | 10.44B |